Clinical Trial Update: Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C [NA]

View source ↗

Summary

A terminated clinical trial assessing the sustained virological response rate of Pegasys plus ribavirin in patients with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Chronic Hepatitis C | NA | Status: TERMINATED